PPT-Review of Non-Daily PrEP Clinical Research and Experience

Robert M Grant MD MPH IAS 2017 July 2017 Paris Disclosures Gilead Sciences donated study medication to US NIH for trials that I have led including iPrEx iPrEx OLE and HPTN 067. Module 1. Presented by . NC TraCS Institute. UNC Office of Clinical Trials. UNC Network of Clinical Research Professionals. Overall Agenda for Orientation. Module 1: . Introduction to Clinical Research, Education, and IRB. Experience in research, assessment and evaluation with a recognised university or research institutes in areas such as disability, autism or Public Health. The Director filling this role would be expected to provide input into the analysis and interpretation of commissioned research projects and provide guidance and input into the design of new research projects in support of Amaze’s principles, particularly that of our “Evidence based” principle to seek data and evidence to underpin decision-making and measurement of outcomes. Specific experience of the National Disability Insurance Scheme and the health system would be desirable. Experience in research, assessment and evaluation with a recognised university or research institutes in areas such as disability, autism or Public Health. The Director filling this role would be expected to provide input into the analysis and interpretation of commissioned research projects and provide guidance and input into the design of new research projects in support of Amaze’s principles, particularly that of our “Evidence based” principle to seek data and evidence to underpin decision-making and measurement of outcomes. Specific experience of the National Disability Insurance Scheme and the health system would be desirable. in . Bangkok . MSM . (HPTN . 067/ADAPT Study). Tareerat . Chemnasiri, . Anchalee . Varangrat, . K. Rivet . Amico. , . Supaporn. . Chaikummao. , . Anupong. . Chitwarakorn. , . Bonnie J. . Dye, . Robert M. . Dawn K. Smith, MD, MS, MPH. Division of HIV/AIDS Prevention. NCHHSTP, CDC. 15 March 2017. Considerations for Job Corps Youth. Why Consider PrEP for Youth?. New HIV Diagnoses in the US for the Most-Affected Sub-populations, 2015. H K, . Fylkesnes. K . M,Sandoy. I F 2016. Sex Differences in HIV Prevalence Persist over Time: Evidence from 18 Countries in Sub-Saharan Africa. . PLoS. One,. 11, e0148502.. 2. . Celum. C L, Delany-. PrEP Considerations for HPX3002/HVTN 706 Susan Buchbinder HVTN Study Chair/San Francisco Site PI PrEP is safe and highly effective against sexual exposures for MSM and TGW 4 Doses/Week has Similar Efficacy to Daily TDF/FTC for MSM PrEP Training for Providers in Clinical Settings (Version 2.0) 2 Welcome! Please sign the registration sheet. Please make a name tag for yourself. Please ta ke a participant manual, notebook, and pen. . Primary Instructor: . Elizabeth Garrett-Mayer, PhD. Professor of Biostatistics, Dept. of Public Health Sciences. Director of Biostatistics, Hollings Cancer Center. Context: K-12 award. Paul . Calabresi. “Putting it All Together. ”. 1. Why the changes to NIH-funded studies involving human subjects?. No policies existed to make sure that the public had access to results from unpublished NIH-funded research . Promote Sexual Health. www.hivguidelines.org. MAY 2022. NYSDOH AIDS Institute Clinical Guidelines Program. Purpose of This Guideline. Increase awareness and knowledge of . PrEP. efficacy among clinicians in NYS.. By: Caitlin Vinyard. HSC Sponsored Projects Office. What is a Clinical Trial?. Clinical trials . or Clinical Study are defined in concurrence with NIH and Office of Human Protections (HRPO) guidelines. . Agenda. Reducing Administrative Burden - Administrative Fees. Billing Coverage Analysis. Research Billing Review. DocuSign – . eConsent. . Advarra Electronic Data Capture. Subject Injury language in the ICF. June, 2024 . MRAM. Carol Rhodes . Office of Sponsored Programs. OSP Clinical Research Web Content. Broadened to cover clinical research in general. Updated in collaboration with HSD and Clinical Trial Office (CTO).